NeuroStemcell is formed to create a world - leading consortium that can take stem cell based therapies for Parkinson's disease (PD) and Huntington's disease (HD) to the clinic. (neurostemcell.org)
NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world - leading consortium that can develop stem cell based therapies for Parkinson's disease and Huntington's disease toward clinical application... Read more» (neurostemcell.org)
What this approval shows is that the readiness of the FDA to work with researchers to move exciting new stem cell based therapies out of the lab and into the clinic.» (robertlanza.com)